Below are the 2 most recent journal entries recorded in smierragatto917's InsaneJournal:

Wednesday, December 7th, 2011
6:34 am	Early treatment with prednisolone or acyclovir in bells palsy - nejm Citing Articles 1 G. Wells, S. Williams, S. C. Davies. (2011) The Department of Health perspective on handling uncertainties in health sciences. Philosophical Transactions on the Royal Society A: Mathematical, Physical and Engineering Sciences 369:1956, 4853-4863 CrossRef 2 Jonathan M. Fishman. (2011) Corticosteroids effective in idiopathic facial nerve palsy (Bell's Palsy) yet not necessarily in idiopathic acute vestibular dysfunction (Vestibular Neuritis). The Laryngoscope 121:11, 2494-2495 CrossRef 3 Eun Woong Ryu, Ho Yun Lee, So Yoon Lee, Moon Suh Park, Seung Geun Yeo. (2011) Clinical manifestations and prognosis of patients with Ramsay Hunt syndrome. American Journal of Otolaryngology CrossRef 4 M. Kunze, S. Arndt, A. Zimmer, M. Foldi, A. Hanjalic-Beck, M. Echternach, R. Birkenhager, A. Aschendorff. (2011) Periphere Fazialisparese in der Schwangerschaft. HNO CrossRef 5 Hartmut Peter Burmeister, Pascal Andreas Thomas Baltzer, Gerd Fabian Volk, Carsten Michael Klingner, Anke Kraft, Matthias Dietzel, Otto Wilhelm Witte, Werner Alois Kaiser, Orlando Guntinas-Lichius. (2011) Evaluation from the early phase of Bells palsy using 3T MRI. European Archives of Oto-Rhino-Laryngology 268:10, 1493-1500 CrossRef 6 Mikael L. -A. Karlberg, Mans Magnusson. (2011) Treatments for Acute Vestibular Neuronitis With Glucocorticoids. Otology & Neurotology 32:7, 1140-1143 CrossRef 7 Jean Tsai, Randall J. Cohrs, Maria A. Nagel, Ravi Mahalingam, D. Scott Schmid, Alexander Choe, Don Gilden. (2011) Reactivation of type 1 hsv simplex virus and varicella zoster virus within an immunosuppressed patient with acute peripheral facial weakness. Journal on the Neurological Sciences CrossRef 8 Susan Coulson, Glen R. Croxson, Roger Adams, Victoria Oey. (2011) Prognostic Factors in Herpes Zoster Oticus (Ramsay Hunt Syndrome). Otology & Neurotology 32:6, 1025-1030 CrossRef 9 Norihiko Takemoto, Arata Horii, Yoshiharu Sakata, Hidenori Inohara. (2011) Prognostic Factors of Peripheral Facial Palsy. Otology & Neurotology 32:6, 1031-1036 CrossRef 10 Jacob Alexander de Ru, Peter Paul G. van Benthem. (2011) Combination Treatment therapy is Preferable for Patients With Ramsay Hunt Syndrome. Otology & Neurotology 32:5, 852-855 CrossRef 11 Andreas Christoph Jenke, Lisa-Marie Stoek, Matthias Zilbauer, Stefan Wirth, Peter Borusiak. (2011) Facial palsy: Etiology, outcome and management in children. European Journal of Paediatric Neurology 15:3, 209-213 CrossRef 12 Valeria Pallavicini, Imma Danes Carreras. (2011) Eficacia de los glucocorticoides y los antivirales en el tratamiento de la paralisis de Bell. Medicina Clinica 136:11, 501-503 CrossRef 13 Dae Han Chung, Dong Choon Park, Jae Yong Byun, Moon Suh Park, So Yoon Lee, Seung Geun Yeo. (2011) Prognosis of patients with recurrent facial palsy. European Archives of Oto-Rhino-Laryngology CrossRef 14 Pauline Lockhart, N Julian Holland, Iain Swan, Lazaro J Teixeira, Pauline Lockhart. 2011. Interventions for Bell's Palsy (idiopathic facial paralysis). . CrossRef 15 Kerrie McAllister, David Walker, Peter T Donnan, Iain Swan, Iain Swan. 2011. Surgical interventions for the early control over Bell's palsy. . CrossRef 16 Jong Dae Lee, Yang-Sun Cho, Ki Hong Jang, Ho Ki Lee, Ki Han Kwon. (2011) Acute Inflammatory Facial Nerve Paralysis. Korean Journal of Otorhinolaryngology-Head and Neck Surgery 54:6, 386 CrossRef 17 Daniel Bremell, Lars Hagberg. (2011) Clinical characteristics and cerebrospinal fluid parameters in patients with peripheral facial palsy attributable to Lyme neuroborreliosis in contrast to facial palsy of unknown origin (Bell's palsy). BMC Infectious Diseases 11:1, 215 CrossRef 18 Christopher W. Mitchell, Tulio E. Bertorini. 2011. Principles and Guidelines of Immunotherapy in Neuromuscular Disorders. , 101-113. CrossRef 19 Sara Axelsson, Thomas Berg, Lars Jonsson, Mats Engstrom, Mervi Kanerva, Anne Pitkaranta, Anna Stjernquist-Desatnik. (2011) Prednisolone in Bell's Palsy In connection with Treatment Start and Age. Otology & Neurotology 32:1, 141-146 CrossRef 20 Ho Yun Lee, Eun Woong Ryu, Soo Wan Park, Su Jin Kim, Seung Geun Yeo, Moon Suh Park. (2011) Analysis of Associated The signs of Bell's Palsy. Korean Journal of Otorhinolaryngology-Head and Neck Surgery 54:10, 683 CrossRef 21 Eric Smouha, Elizabeth Toh, Barry M. Schaitkin. (2011) Medical procedures of Bell's palsy: Current attitudes. The Laryngoscopen/a-n/a CrossRef 22 Kazuhiro Kawaguchi, Hiroo Inamura, Hiroyuki Maeyama, Hidehiro Kohsyu, Nobuaki Takahashi, Yasuhiro Abe, Kenichi Ishii, Takatoshi Furukawa, Masaru Aoyagi. (2011) Clinical Facial Nerve Clinic Survey. Practica oto-rhino-laryngologica. Suppl. 130, 18-25 CrossRef 23 Y Ramakrishnan, S Alam, A Kotecha, D Gillett, A D'Souza. (2010) Reanimation following facial palsy: present and future directions. The Journal of Laryngology & Otology 124:11, 1146-1152 CrossRef 24 M. Tariq Bhatti, Jade S. Schiffman, Anastas F. Pass, Rosa A. Tang. (2010) Neuro-ophthalmologic Complications and Manifestations of Lower and upper Motor Neuron Facial Paresis. Current Neurology and Neuroscience Reports 10:6, 448-458 CrossRef 25 HV Worthington, A-M Glenny, L Fernandez Mauleffinch, F Daly, J Clarkson. (2010) Using Cochrane reviews for oral diseases. Oral Diseases 16:7, 592-596 CrossRef 26 Kalipso Chalkidou, Tom Walley. (2010) Using Comparative Effectiveness Research to tell Policy and exercise in england NHS. PharmacoEconomics 28:10, 799-811 CrossRef 27 Elin Marsk, Lalle Hammarstedt, Thomas Berg, Mats Engstrom, Lars Jonsson, Malou Hultcrantz. (2010) Early Deterioration in Bell's Palsy. Otology & Neurotology1 CrossRef 28 Y. L. Lo, S. Fook-Chong, T. H. Leoh, Y. F. Dan, M. P. Lee, H. Y. Gan, L. L. Chan. (2010) High-resolution ultrasound inside evaluation and prognosis of Bells palsy. European Journal of Neurology 17:6, 885-889 CrossRef 29 M. Grosheva, D. Beutner, G. F. Volk, C. Wittekindt, O. Guntinas-Lichius. (2010) Die idiopathische Fazialisparese. HNO 58:5, 419-425 CrossRef 30 O. Guntinas-Lichius. (2010) Erkrankungen des N. facialis. HNO 58:5, 417-418 CrossRef 31 P. Wallace. (2010) Research normally practice and primary care. InnovAiT 3:5, 298-301 CrossRef 32 H E Cha, M K Baek, J H Yoon, B K Yoon, M J Kim, J H Lee. (2010) Clinical features and therapy for facial nerve paralysis in youngsters: analysis of 24 cases. The Journal of Laryngology & Otology 124:04, 402 CrossRef 33 Rodrigo A Salinas, Gonzalo Alvarez, Fergus Daly, Joaquim Ferreira, Rodrigo A Salinas. 2010. Corticosteroids for Bell's palsy (idiopathic facial paralysis). . CrossRef 34 J. K. Hoang, J. D. Eastwood, C. M. Glastonbury. (2010) What's inside a name Eponyms in head and neck imaging. Clinical Radiology 65:3, 237-245 CrossRef 35 &NA;. (2010) Whats inside Literature. Journal of Clinical Neuromuscular Disease 11:3, 158-163 CrossRef 36 Greg M. Thaera, Kay E. Wellik, David M. Barrs, Erika D. Driver Dunckley, Dean M. Wingerchuk, Bart M. Demaerschalk. (2010) Are Corticosteroid and Antiviral Treatments Effective for Bell Palsy. The Neurologist 16:2, 138-140 CrossRef 37 C Bodenez, I Bernat, J-C Willer, P Barre, G Lamas, F Tankere. (2010) Facial nerve decompression for idiopathic Bell's palsy: report of 13 cases and literature review. The Journal of Laryngology & Otology 124:03, 272 CrossRef 38 Cheng-Hsien Wang, Yu-Che Chang, Hong-Mo Shih, Chun-Yu Chen, Jih-Chang Chen. (2010) Facial Palsy in kids. Pediatric Emergency Care 26:2, 121-125 CrossRef 39 Thomas E. Linder, Wael Abdelkafy, Sandra Cavero-Vanek. (2010) The Management of Peripheral Facial Nerve Palsy. Otology & Neurotology 31:2, 319-327 CrossRef 40 G. G. Browning. (2010) Bells palsy: an assessment of three systematic reviews of steroid and anti-viral therapy. Clinical Otolaryngology 35:1, 56-58 CrossRef 41 Jin Kim, In Seok Moon, Won-Sang Lee. (2010) Effect of delayed decompression after early steroid treatment on facial purpose of patients with facial paralysis. Acta Oto-laryngologica 130:1, 179-184 CrossRef 42 Jessica Robinson-Papp, David M. Simpson. (2009) Neuromuscular diseases associated with HIV-1 infection. Muscle & Nerve 40:6, 1043-1053 CrossRef 43 Ribhi Hazin, Babak Azizzadeh, M Tariq Bhatti. (2009) Medical and surgical management of facial nerve palsy. Current Opinion in Ophthalmology 20:6, 440-450 CrossRef 44 Pauline Lockhart, Fergus Daly, Marie Pitkethly, Natalia Comerford, Frank Sullivan, Pauline Lockhart. 2009. Antiviral strategy to Bell's palsy (idiopathic facial paralysis). . CrossRef 45 Thomas Berg, Elin Marsk, Mats Engstrom, Malou Hultcrantz, Nermin Hadziosmanovic, Lars Jonsson. (2009) The effects of study design and analysis methods on recovery rates in Bell's palsy. The Laryngoscope 119:10, 2046-2050 CrossRef 46 Thomas Berg, Sara Axelsson, Mats Engstrom, Anna Stjernquist-Desatnik, Anne Pitkaranta, Mervi Kanerva, Lars Jonsson. (2009) The path of Pain in Bell's Palsy. Otology & Neurotology 30:6, 842-846 CrossRef 47 C. Simon. (2009) Peripheral neuropathy. InnovAiT 2:9, 538-545 CrossRef 48 Gregory S. Kosmorsky, Alyssa Fiddler. (2009) Selected lid problems in neurologic practice. Current Neurology and Neuroscience Reports 9:5, 390-395 CrossRef 49 Don Gilden. (2009) Is antiviral medication for severe Bell's palsy still useful Author's reply. The Lancet Neurology 8:6, 510 CrossRef 50 Robert S. Crausman, Eleanor M. Summerhill, F. Dennis McCool. (2009) Idiopathic Diaphragmatic Paralysis: Bells Palsy with the Diaphragm. Lung 187:3, 153-157 CrossRef 51 Sebastian Oliver Decker, Frieder Keller, Jens Mayer, Sylvia Stracke. (2009) 2 times a day Fractionated Dose Administration of Prednisolone Compared to Standard Once Daily Administration to Patients with Glomerulonephritis or with Kidney Transplants*. Medizinische Klinik 104:6, 429-433 CrossRef 52 J Alexander de Ru, Peter Paul G van Benthem, Luuk M Janssen. (2009) Is antiviral medication for severe Bell's palsy still useful levitra online without a prescription. The Lancet Neurology 8:6, 509 CrossRef 53 Rodrigo A Salinas, Gonzalo Alvarez, Joaquim Ferreira, Rodrigo A Salinas. 2009. Corticosteroids for Bell's palsy (idiopathic facial paralysis). . CrossRef 54 R. Hernandez, F Sullivan, P Donnan, I Swan, L Vale, . (2009) Economic evaluation of early administration of prednisolone and/or aciclovir for the therapy for Bell's palsy. Family Practice 26:2, 137-144 CrossRef 55 Kenneth L Tyler. (2009) Prednisolonebut not antiviral drugsimproves outcome in patients with Bell's palsy. Nature Clinical Practice Neurology 5:2, 74-75 CrossRef 56 Shigeru Hoshida, Miyako Hatano, Mitsuru Furukawa, Makoto Ito. (2009) Neuroprotective link between vitamin e d-alpha on adult rat motor neurones following facial nerve avulsion. Acta Oto-laryngologica 129:3, 330-336 CrossRef 57 Won Sang Lee, Jin Kim. (2009) Facial Nerve Paralysis and Surgical Management. Journal with the Korean Medical Association 52:8, 807 CrossRef 58 Don Gilden. (2008) Therapy for Bell's palsythe pendulum has swung time for steroids alone. The Lancet Neurology 7:11, 976-977 CrossRef 59 Martina Minnerop, Martin Herbst, Rolf Fimmers, Bertfried Matz, Thomas Klockgether, Ullrich Wullner. (2008) Bells palsy. Journal of Neurology 255:11, 1726-1730 CrossRef 60 Jong-Lyel Roh, Chan Il Park. (2008) A prospective, randomized trial for use of prednisolone in patients with facial nerve paralysis after parotidectomy. The American Journal of Surgery 196:5, 746-750 CrossRef 61 Mats Engstrom, Thomas Berg, Anna Stjernquist-Desatnik, Sara Axelsson, Anne Pitkaranta, Malou Hultcrantz, Mervi Kanerva, Per Hanner, Lars Jonsson. (2008) Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial. The Lancet Neurology 7:11, 993-1000 CrossRef 62 Iain Swan, Peter Donnan, Kerrie McAllister, David Walker, Iain Swan. 2008. Surgical interventions for the early treatments for Bell's palsy. . CrossRef 63 Naohito Hato, Naoki Sawai, Masato Teraoka, Hiroyuki Wakisaka, Hirotaka Takahashi, Yasuyuki Hinohira, Kiyofumi Gyo. (2008) Valacyclovir for that treatment of Bell's palsy. Expert Opinion on Pharmacotherapy 9:14, 2531-2536 CrossRef 64 Naohito Hato, Shingo Murakami, Kiyofumi Gyo. (2008) Treatment for Bell's palsy Authors' reply. The Lancet 372:9645, 1220-1221 CrossRef 65 Richard J Davenport, Frank Sullivan, Blair Smith, Jill Morrison, Brian McKinstry. (2008) Treatment for Bell's palsy. The Lancet 372:9645, 1219-1220 CrossRef 66 Daron Cope, Ronaldo Bova. (2008) Steroids in Otolaryngology. The Laryngoscope 118:9, 1556-1560 CrossRef 67 Lazaro Juliano Teixeira, Bernardo Garcia de Oliveira Soares, Vanessa Pedrosa Vieira, Gilmar F Prado, Lazaro Juliano Teixeira. 2008. Physical rehabilitation for Bells palsy (idiopathic facial paralysis). . CrossRef 68 N Julian Holland, Jonathan M Bernstein, John Hamilton, N Julian Holland. 2008. Hyperbaric oxygen therapy for Bell's palsy. . CrossRef 69 Zainab A. Malik, Nathan Litman. (2008) A 17-Year-Old Boy With Facial Palsy and Hyperacusis. The Pediatric Infectious Disease Journal 27:7, 646, 674-675 CrossRef 70 P. Duhaut. (2008) Lexamen national classant (ENC) quatre annees apres sa mise en place: quen penser. La Revue de Medecine Interne 29:7, 531-534 CrossRef 71 Josef Finsterer. (2008) Control over peripheral facial nerve palsy. European Archives of Oto-Rhino-Laryngology 265:7, 743-752 CrossRef 72 Richard A. C. Hughes. (2008) Treating nerves: a trip to arms. Journal with the Peripheral Nervous System 13:2, 105-111 CrossRef 73 John J. Halperin. (2008) Neurological system Lyme Disease. Infectious Disease Clinics of North America 22:2, 261-274 CrossRef 74 Hnin Khine, Marguerite Mayers, Jeffrey R. Avner, Amy Fox, Betsy Herold, David L. Goldman. (2008) ASSOCIATION BETWEEN HERPES SIMPLEX VIRUS-1 INFECTION AND IDIOPATHIC UNILATERAL FACIAL PARALYSIS IN CHILDREN AND ADOLESCENTS. The Pediatric Infectious Disease Journal 27:5, 468-469 CrossRef 75 Naohito Hato, Shingo Murakami, Kiyofumi Gyo. (2008) Steroid and antiviral strategy to Bell's palsy. The Lancet 371:9627, 1818-1820 CrossRef 76 (2008) Prednisolone or Acyclovir in Bell's Palsy. Northeastern Journal of medication 358:3, 306-307 Full Text 77 Kurt Samson. (2007) Antiviral Therapy Found to own Little Benefit in Bell Palsy; Prednisolone Monotherapy Is ideally suited for. Neurology Today 7:22, 1,24-25 CrossRef 78 Gilden, Donald H. , Tyler, Kenneth L. , . (2007) Bell's Palsy Is Glucocorticoid Treatment Enough. Northeastern Journal of Medicine 357:16, 1653-1655 Full Text 79 Rodrigo A Salinas, Gonzalo Alvarez, Joaquim Ferreira, Rodrigo A Salinas. 2004. Corticosteroids for Bell's palsy (idiopathic facial paralysis). . CrossRef . Current Mood: ditzy (Comment on this)
6:26 am	Duloxetine with the treatment of dysthymia - full text view - clinicaltrials.gov The reason for this research is always to obtain home elevators the security and effectiveness of duloxetine (Cymbalta) inside the management of dysthymia. Duloxetine may be licensed by the federal Fda standards with the management of depression. cipro online no prescription The use of duloxetine for treatment of dysthymia is regarded as experimental. Dysthymia is described as chronic, low-grade depression, seen as feeling low or depressed, that may last for some years. Additional symptoms occasionally includes: poor appetite or overeating; insomnia or sleeping excessive; low energy or fatigue; low self-esteem; poor concentration or difficulty making decisions; and feelings of hopelessness. Dysthymia affects 3-6% from the general population, but can be an underdiagnosed and undertreated disorder. In double-blind, placebo-controlled clinical trials of antidepressant medications, dysthymia response rates remain 60%, in comparison with the normal placebo response rate of around 30%. Duloxetine is not studied inside the therapy for dysthymia, but has revealed results in the treatment of major depression. Within a 9-week, double-blind, placebo-controlled study of 257 patients with depressive disorder, 65% taken care of immediately duloxetine 60mg/day, when compared with 43% to placebo. According to these results, it's highly likely that duloxetine are going to be very effective treatments for dysthymia. This research study is being conducted at Stanford University Facility that has a total of 24 patients, age 18 and above, with dysthymia. In case study, subjects get duloxetine for 3 months. trial ed pack online without a prescription This is undoubtedly an open-label study, meaning that every subject receives the research medication. In total, subjects emerged for 10 visits across 13 weeks. At every visit subjects' heartrate, high blood pressure and weight measurements will be obtained. At each visit study personnel will interview subjects regarding their symptoms, monitor side effects and ask these to complete study questionnaires. Beginning at the second visit, subjects receive duloxetine 60 mg/day. If they experience unwanted side effects, the dose is usually decreased to 30 mg/day for several days, and often will be increased time for 60 mg/day in the end from the first week. If subjects can't tolerate a dose of 60 mg/day due to uncomfortable side effects, they will be withdrawn in the study. At the finish of About 6 weeks, when they have been not responded to case study medication (as driven by doctor ratings based on subjects' reports), the dose of duloxetine will likely be increased to 120 mg/day, unless subjects have troubling side effects. Subjects go on the minimum dose thats liable to bring about remission or the maximum tolerated dose to the remaining About 6 weeks. Medication dosing will be flexible and determined by tolerance (unwanted effects) and therapeutic effect. . Current Mood: happy (Comment on this)